Research Site

Pilar B1629ODT

3 studies enrolling now · 6 studies all time

What they study most

Asthma, Carcinoma, Non-Small Cell Lung, Non-Cirrhotic Non-alcoholic Steatohepatitis With Fibrosis, Non-small Cell Lung Cancer, Non-squamous Non-small Cell Lung Cancer

Studies at this site

• A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer — Recruiting now
• A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC — Recruiting now
• A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) — Recruiting now
• Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma — Completed
• Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma — Completed
• A Study in Participants With Non-cirrhotic NASH With Fibrosis — Completed